Related Experiment Video
Updated: Aug 15, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Chromosomal abnormalities in fetuses with congenital heart disease: a meta-analysis
Huaming Wang1, Xi Lin2, Guorong Lyu3,4
1Department of Ultrasound, The Second Affiliated Hospital of Fujian Medical University, Zhongshan Load, Quanzhou, Fujian, China.
Insights
Congenital heart disease (CHD) in fetuses is frequently linked to chromosomal abnormalities. Further genetic testing like chromosomal microarray is recommended for non-isolated CHD and septal defects.
Area of Science:
- Medical Genetics
- Fetal Medicine
- Cardiology
Background:
- Congenital heart disease (CHD) is a significant concern in fetal development.
- Chromosomal abnormalities are known risk factors associated with CHD.
- Evaluating the precise risk and types of chromosomal abnormalities in fetuses with CHD is crucial for accurate diagnosis and management.
Approach:
- A comprehensive meta-analysis was conducted, synthesizing data from 45 studies.
- Literature databases were systematically searched up to January 2022 for studies on fetal CHD and chromosomal abnormalities.
- Prevalence of overall chromosomal abnormalities, aneuploidy, 22q11 deletion, copy number variants (CNVs), and variants of unknown significance (VOUS) were analyzed.
Key Points:
- The pooled prevalence of chromosomal abnormalities in fetuses with CHD was 23%, with aneuploidy at 19%.
- Non-isolated CHD showed significantly higher rates of chromosomal abnormalities (ORs 3.08-4.02) compared to isolated CHD.
- Septal defects had a higher incidence of chromosomal abnormalities (ORs 1.60-3.61) than conotruncal and other defect types.
Conclusions:
- Congenital heart disease is strongly associated with chromosomal abnormalities.
- Chromosomal microarray is recommended for detecting submicroscopic abnormalities when karyotyping or FISH is normal, particularly in non-isolated CHD and septal defects.
- These findings underscore the importance of genetic evaluation in fetuses diagnosed with CHD.
Purpose:
The aim of this meta-analysis was to evaluate the risk of chromosomal abnormalities in fetuses with congenital heart disease (CHD).
Methods:
Four literature databases were searched until 17th January 2022 using the relevant medical subject heading terms, word variants, and keywords for "congenital heart defect, fetal, and chromosomal abnormalities". The prevalence of overall chromosomal abnormality, aneuploidy, 22q11 deletion, other copy number variants (CNVs), and variants of unknown significance (VOUS) was analyzed.
Results:
45 studies met the inclusion criteria for the analysis. The pooled proportion of overall chromosomal abnormalities, aneuploidy, 22q11 deletion, and other CNVs in fetuses with CHD was 23% (95% CI: 20-26%), 19% (95% CI, 16-22%), 2% (95% CI, 2-3%), and 4% (95% CI, 3-5%), respectively. The incidence of overall chromosomal abnormalities, aneuploidy, and other CNVs in non-isolated CHD was higher than in isolated CHD, with odds ratios of 3.08, 3.45, and 4.02, respectively. The incidence of overall chromosomal abnormalities in septal defects was higher than in conotruncal defects and other defects, with odds ratios of 1.60 and 3.61, respectively. In addition, the pooled proportion of VOUS in CHD was 4%.
Conclusion:
CHD is commonly associated with chromosomal abnormalities. If karyotyping or fluorescence in situ hybridization is normal, chromosomal microarray should be performed to look for submicroscopic abnormalities, especially in fetuses with non-isolated CHD and septal defects.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Teratogenicity
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies for Cardiovascular System V: CT

